|
| BPN Monday Poster Session |
| Monday, May 26, 2025 |
| 1:00 PM–3:00 PM |
| Convention Center, Lower Level, Hall C |
| Chair: Maria G. Valdovinos (Drake University) |
|
| 59. The Value of e-Cigarettes and Alcohol: Implications for Treatment and Policy for Young Adult Populations |
| Area: BPN; Domain: Applied Research |
| SYDNEY BATCHELDER (Eastern Michigan University), Grant Saba (Eastern Michigan University) |
| Discussant: Maria G. Valdovinos (Drake University) |
| Abstract: Young adults use both alcohol and e-cigarettes at alarming rates; 19% reported using e-cigarettes in the past month (Schulenberg et al., 2021) and 80% of vapers also used alcohol (Buu et al., 2020). Past research has evaluated interactions between alcohol and combustible cigarette use (Frie et al., 2022). However, e-cigarette pharmacology and metabolism are unique from cigarettes, therefore, further investigation is required. The present study asked young adults from Eastern Michigan University (anticipated N = 300) about their: 1) cigarette, e-cigarette, and alcohol use; 2) their hypothetical alcohol and e-cigarette consumption; and 3) their anxiety and depressive symptoms. We hypothesize e-cigarette users will report greater consumption of alcohol than non-users, and individuals with problematic alcohol use will report greater consumption of e-cigarette puffs than individuals without problematic alcohol use. These results expand research showing cigarette smokers reported greater alcohol consumption compared to non-smokers (Yurasek et al., 2013) and e-cigarette users have greater odds of having an alcohol use disorder than non-users (Gelino et al., 2023). Overall, this research will inform decisions for policy and treatment, such as e-cigarette screening in healthcare, increasing e-cigarette response cost (e.g., increasing age restrictions), and increasing access to polysubstance treatment. |
| |
|
| 60. Utilizing Qualitative Research to Improve the Objective Measurement of Cigarette Smoking Among Adults With Intellectual and Developmental Disabilities |
| Area: BPN; Domain: Applied Research |
| SEAN REGNIER (University of Kentucky, College of Medicine), Martha Tillson (University of Kentucky), Thomas Shellenberg (University of Kentucky), Joshua Anthony Lile (University of Kentucky), William Stoops (University of Kentucky) |
| Discussant: Amanda M Muñoz-Martinez (Universidad de Los Andes, Colombia) |
| Abstract: People with disabilities (PWD) have higher smoking rates and nicotine dependence but are underrepresented in smoking research. Despite this health concern, there is a concerning lack of research on cigarette smoking among PWD, including the implementation of objective smoking measurement technology, a key feature of behavior analytic tobacco interventions. Adapting breath carbon monoxide (CO) monitoring for PWD could promote health equity. This study explores PWD and provider perspectives on using the iCOquit® Smokerlyzer® and identifies improvements for inclusivity. In an ongoing mixed-methods project, PWD who smoke and adult day training providers complete semi-structured interviews and usability surveys. After a device demonstration, participants share preferences, challenges, and suggest adaptations to enhance usability. Qualitative data are analyzed using a hybrid thematic approach. Participants recommended the Smokerlyzer® but highlighted the need for automated reminders and assistance when using the device. Providers suggested adaptations such as visual aids, gamification, smoking education, and incentives for providing CO samples. They also noted that the device would not disrupt program activities. This study provides preliminary data to suggest existing smoking monitoring technology could be adapted for PWD and offers recommendations for changes to enhance usability. Further validation and testing of this technology are needed. |
| |
|
| 61. Do the Adaptogenic Mushrooms, Cordyceps Militaris and Hericium Erinaceus, Produce Caffeine-Like Discriminative-Stimulus Effects? |
| Area: BPN; Domain: Basic Research |
| STEPHEN CULLINAN (West Virginia University), Karen G. Anderson (West Virginia University) |
| Discussant: Maria G. Valdovinos (Drake University) |
| Abstract: Caffeine is one of the most widely consumed drugs in the United States, but its excessive consumption increases the risk of heart disease, sleep problems, and anxiety. In response to these issues, there has been a rise in efforts to find safer alternatives to caffeine while maintaining similar subjective effects. The adaptogenic mushroom, cordyceps, is claimed to have similar energy and mood enhancing effects as caffeine, however, there is limited research that directly compares its effects to caffeine. Drug-discrimination paradigms, in which rats are trained to discriminate between caffeine and saline, may be used to compare the discriminative-stimulus effects of cordyceps to those of caffeine. After discrimination is established, rats are given varying doses of caffeine and cordyceps extract to produce dose-response generalization gradients. Substitution of cordyceps for caffeine, effects on response rates, and relative potency, as determined by ED50s, will be presented. If cordyceps is found to at least partially generalize to caffeine, it may be suggested there are shared stimulus properties and this adaptogen may function as effective substitutes for caffeine. |
| |
| |